GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » Research & Development

CMIC HOLDINGS Co (TSE:2309) Research & Development : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CMIC HOLDINGS Co's Research & Development for the three months ended in Dec. 2023 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil.


CMIC HOLDINGS Co Research & Development Historical Data

The historical data trend for CMIC HOLDINGS Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co Research & Development Chart

CMIC HOLDINGS Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CMIC HOLDINGS Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CMIC HOLDINGS Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CMIC HOLDINGS Co  (TSE:2309) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


CMIC HOLDINGS Co Research & Development Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


CMIC HOLDINGS Co (TSE:2309) Business Description

Traded in Other Exchanges
N/A
Address
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines